Difference between revisions of "Kraggerud SM, et al. Endocr. Rev. (2013) cited as Ref 619 in DOI: 10.1038/s41392-020-0110-5 (Q9882)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): Endocr. Rev., #quickstatements; #temporary_batch_1590006349955) |
(Created claim: Volume (P103): 34, #quickstatements; #temporary_batch_1590009084631) |
||
| Property / Volume | |||
| + | 34 | ||
| Property / Volume: 34 / rank | |||
| + | Normal rank | ||
Revision as of 21:32, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Kraggerud SM, et al. Endocr. Rev. (2013) cited as Ref 619 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Kraggerud SM
0 references
2013
0 references
Endocr. Rev.
0 references
34
0 references
